Article Information
PubMed
Published By
History
- Received March 16, 2022
- Revision received July 31, 2022
- Accepted August 10, 2022
- Published online September 9, 2022.
Copyright & Usage
Copyright © 2022 Gerbatin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Rogério R. Gerbatin1,2,
- Joana Augusto1,4,
- Gareth Morris1,2,5,
- Aoife Campbell1,2,
- Jesper Worm6,
- Elena Langa1,2,
- Cristina R. Reschke1,2,3,* and
- David C. Henshall1,2,*
- 1Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland
- 2FutureNeuro SFI Research Centre, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland
- 3School of Pharmacy and Biomedical Sciences, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland
- 4Department of Physiology, Faculty of Medicine, Trinity College Dublin, Dublin, D02 PN40, Ireland
- 5Department of Neuroscience, Physiology and Pharmacology, University College London, London, WC1E 6BT, United Kingdom
- 6Roche Innovation Center Copenhagen, Copenhagen, CH-4070, Denmark
- Correspondence should be addressed to David C. Henshall at dhenshall{at}rcsi.ie.
Author contributions
Author contributions: D.C.H., R.R.G., J.W., and C.R.R. designed research; D.C.H. contributed unpublished reagents/analytic tools; R.R.G., J.A., G.M., A.C., E.L., and C.R.R. performed research; R.G. analyzed data; R.R.G. wrote the paper.
↵* C.R.R. and D.C.H. contributed equally to this work.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Science Foundation Ireland (SFI) Grant 16/RC/3948, the European Regional Development Fund, FutureNeuro industry partners, the Charitable Infirmary Charitable Trust Grant 108, the Marie Skłodowska-Curie Actions Grant H2020-MSCA-IF-2018 840262 (to G.M.), the Emerging Leader Fellowship Award F2102 Morris, and F. Hoffman-La Roche Ltd. C.R.R. was supported by CURE epilepsy.
Funding
Science Fundation Ireland (SFI)
16/RC/3948Charitable Infirmary Charitable Trust
Grant 108Marie Skłodowska-Curie Actions
H2020-MSCA-IF-2018 840262Emerging Leader Fellowship Award
F2102 Morris
Other Version
- You are viewing the most recent version of this article.
- previous version (September 09, 2022).
Article usage
In this issue
Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome
